NeuroPace, Inc. develops and sells RNS system, a brain-responsive neuromodulation system for treatingmedically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company was incorporated in 1997 and is headquartered in Mountain View, California.